SectorSurfer Logo

Is your portfolio prepared for the next market shift? SectorSurfer's award-winning algorithms help investors achieve higher returns with lower risk through automated sector rotation and StormGuard protection.

Learn how our proprietary technology identifies momentum leaders in any market condition, automatically shifting to defensive positions during downturns.

Start Your Free Trial

#InvestingStrategy #SectorRotation #PortfolioManagement #WealthBuilding

SectorSurfer Dashboard

Higher Returns with Lower Risk: The SectorSurfer Advantage

PCVX Vaxcyte Inc

Exchange: NASDAQ

Asset Type: Common Stock Country: USA
Market Cap
$3.8B
P/E Ratio
N/A
EPS
$-3.99
Dividend Yield
N/A

Company Overview

Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City, California.
Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Currency
USD
Fiscal Year End
December
Latest Quarter
2025-03-31
Official Website
https://vaxcyte.com

Performance

1 Week 1 Month 1 Year 3 Years 5 Years YTD 2025 2024 Since Inception
+11.40% -5.39% +62.14% +12.02% +22.07% +46.36% N/A N/A +15.95%

Performance Charts


Monthly Returns (%)

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2020 - - - - - - -0.6% +44.2% +9.1% -24.3% -14.1% -17.2%
2021 -7.7% -4.0% -16.2% -6.0% +13.5% +6.8% -3.7% +21.0% -3.3% -7.8% -12.9% +16.7%
2022 -20.0% +21.7% +4.2% +0.3% -0.9% -9.3% +6.1% +13.3% -8.3% +81.7% +5.6% +4.1%
2023 -5.4% -9.7% -8.5% +14.3% +15.6% +0.9% -3.8% +8.0% -1.8% -5.7% +7.6% +21.3%
2024 +13.7% +3.4% -7.5% -11.4% +16.1% +7.5% +4.5% +2.4% +41.5% -6.9% -11.3% -13.2%
2025 +7.9% -17.3% -48.3% -5.1% -9.4% +0.1% +4.4% -9.3% +17.0% +25.7% +9.6% -7.0%
2026 +16.1% +15.3% -5.9% -1.5% -10.2% +13.1% -7.0% +12.3% -6.3% +9.0% +7.0% -
< -5% -5% to -2% -2% to 0% 0% 0% to +2% +2% to +5% > +5%

Top ETF Holdings

ETFs that hold PCVX as a significant position:

ETF Ticker ETF Name Weight in ETF
MEDI Harbor Health Care ETF 2.7 %
JXX Janus Henderson Transformational Growth ETF 1.4 %
VTWG Vanguard Russell 2000 Growth ETF 0.7 %
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.5 %
SCDS JPMorgan Fundamental Data Science Small Core ETF 0.4 %
IWO iShares Russell 2000 Growth ETF 0.4 %
VTWO Vanguard Russell 2000 ETF 0.3 %
VBK Vanguard Small Cap Growth ETF 0.3 %
SMAP Amplify Small-Mid Cap Equity ETF 0.3 %
NUSC Nuveen ESG Small-Cap ETF 0.3 %
Top 10 ETF holdings shown.

Valuation Metrics

Market Capitalization $3.8B
P/E Ratio (TTM) N/A
Forward P/E N/A
PEG Ratio N/A
Price/Book 1.19
Price/Sales (TTM) N/A
EV/Revenue N/A
EV/EBITDA -14.43

Profitability & Returns

Profit Margin 0.00%
Operating Margin (TTM) 0.00%
Return on Assets (TTM) -14.50%
Return on Equity (TTM) -19.70%
Revenue (TTM) $0
Gross Profit (TTM) $-75M
EBITDA $-626.9M
Beta 1.27

Per Share Metrics

Earnings Per Share (EPS) $-3.99
Diluted EPS (TTM) $-3.99
Revenue Per Share (TTM) $0.00
Book Value Per Share $24.82
Shares Outstanding 129M

Growth Metrics

Quarterly Earnings Growth (YoY) 0.00%
Quarterly Revenue Growth (YoY) 0.00%
52 Week High $121.06
52 Week Low $27.66
50 Day Moving Average $46.64
200 Day Moving Average $81.81

Dividend Information

Dividend Yield
N/A
Dividend Per Share
N/A
Dividend Date
None
Ex-Dividend Date
None

Company Information

Address

353 HATCH DR, FOSTER CITY, CA, US

Additional Details

CIK
1649094
Official Website
https://vaxcyte.com
Stock Profile for PCVX. Data intended for informational purposes only. © 2026